India Respiratory Monitoring Market By Diagnostic and Monitoring Devices (Spirometers, Sleep Test Devices, Peak Flow Meters, Pulse Oximeters, Capnographs, Others), By Type (Therapeutic Devices, Disposables), By End User (Home care, Hospitals, Ambulatory Surgical Centers, Specialty Clinics), By Region and Competition, Forecast & Opportunities, 2020-2030F

Market Overview

India Respiratory Monitoring Market was valued at USD 752.11 Million in 2024 and is expected to reach USD 1118.68 Million by 2030 with a CAGR of 7.04% during the forecast period. Respiratory monitoring, a vital aspect of medical care, involves the careful observation and assessment of an individual's breathing patterns and rates. This crucial practice ensures the maintenance of proper lung function and enables early detection of any potential respiratory complications.

It finds extensive application in various medical settings, such as critical care units, surgical procedures, and the management of chronic respiratory diseases. Respiratory monitoring systems encompass both invasive and non-invasive methods, offering a comprehensive approach to evaluating respiratory health. These systems utilize an array of sophisticated tools, including spirometers, oximeters, and capnographs, to provide accurate and detailed measurements.

By continuously monitoring respiratory parameters, healthcare professionals can promptly identify deviations from normal patterns, enabling timely interventions and optimizing patient care. Through the integration of advanced monitoring technologies, respiratory monitoring plays a crucial role in enhancing patient safety and improving overall healthcare outcomes. Its continuous evolution and refinement contribute to the ongoing advancements in respiratory medicine, ensuring that individuals receive the highest level of care and support for their respiratory well-being.

Download Free Sample Report

Key Market Drivers

Increasing Prevalence of Respiratory Disorders

The increasing prevalence of respiratory disorders is undeniably fueling the demand for respiratory monitoring devices. Respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and interstitial lung diseases have become more widespread in recent years.  With a higher incidence of respiratory disorders, there is a heightened need for early detection and accurate diagnosis. Respiratory monitoring devices, including spirometers and oximeters, play a critical role in assessing lung function, identifying abnormalities, and facilitating prompt intervention. 

According to a 2024 report, respiratory system diseases represent the largest medical category in India, accounting for 15.3% of all prescriptions issued to patients with various conditions. Endocrine and metabolic diseases, such as diabetes, rank second with a 13.5% share of total prescriptions, followed by gastrointestinal and circulatory diseases (including hypertension and cholesterol disorders). Additionally, within respiratory system diseases, upper respiratory tract infections (URTI) make up 27% of cases, making them the most prevalent type of respiratory illness in 2024.

Many respiratory conditions, particularly COPD and asthma, require ongoing management to control symptoms and prevent exacerbations. Respiratory monitoring devices empower patients to monitor their lung function at home, providing valuable data for healthcare providers to optimize treatment plans.  Respiratory monitoring devices are indispensable tools in clinical research and trials for evaluating the effectiveness of new respiratory therapies and interventions. This drives the demand for specialized monitoring technologies that can provide accurate and reliable data.

The increasing prevalence of respiratory disorders has led to a growing demand for respiratory monitoring devices. These devices are essential for early detection, effective management, and improved quality of life for individuals affected by respiratory diseases. As healthcare systems continue to prioritize respiratory health, the demand for innovative and accessible monitoring solutions is expected to persist and evolve.

Technological Advancements in Respiratory Monitoring Devices

Technological advancements in respiratory monitoring are significantly driving the demand for respiratory monitoring devices. These innovations have revolutionized the field of healthcare, providing more accurate, convenient, and patient-centric ways to assess and manage respiratory conditions. Miniaturization of sensors and devices has led to the development of portable and wearable respiratory monitoring solutions.

Patients can now track their lung function and oxygen levels in real-time, empowering them to actively manage their respiratory health. The convenience and ease of use of these devices have fueled their demand. Many respiratory monitoring devices can now seamlessly integrate with smartphones and tablets through dedicated apps. This integration not only enhances data accessibility but also encourages patient engagement in tracking their respiratory health, driving the adoption of these devices.

In September 2023, the Indian Institute of Technology Kanpur (IITK) introduced a groundbreaking technology known as the "Continuous Lung Health Monitoring System." This innovation was developed collaboratively by researchers from IIT Kanpur, IIT Kharagpur, and the International Institute of Information Technology (IIIT) Naya Raipur, with financial backing from the Ministry of Electronics and Information Technology (MeitY), Government of India. The technology, secured under Indian Patent Application No. 202311027111, offers a cost-effective, non-intrusive, and compact solution for healthcare providers to continuously monitor patients' lung health. Continuous monitoring devices, such as wearable pulse oximeters, offer real-time data on oxygen saturation and respiratory rate. This continuous feedback is particularly beneficial for individuals with chronic respiratory conditions, increasing the demand for these devices.

Increasing Applications in Home care Settings

Increasing application of respiratory monitoring in home care settings is becoming a major growth driver in India because patients with chronic conditions such as COPD, asthma, sleep-disordered breathing, and post-illness respiratory weakness increasingly need continuous observation outside hospitals. Home-based monitoring fits well with the broader shift toward patient-centered care, allowing individuals and caregivers to track oxygen saturation, ventilation support, and symptom progression more regularly while reducing repeated hospital visits and travel burdens. This is especially relevant in India, where telemedicine and hybrid care models are helping expand access to long-term respiratory management in both urban and underserved areas, making pulse oximeters, CPAP and BiPAP systems, oxygen concentrators, and related home-use monitoring tools more integral to everyday care pathways.

The move toward home care also improves adherence and timely intervention, since patients can identify deteriorating lung function earlier and clinicians can support remote follow-up more efficiently than with episodic facility-based monitoring alone. For Instance, Apollo Homecare now offers a broad home respiratory portfolio that includes pulse oximeters, CPAP and BiPAP machines, ventilators, and oxygen concentrators with capacities up to 10 litres per minute, while an AIIMS Jodhpur study found that a 12-week home-based pulmonary rehabilitation program in 62 COPD patients improved both lung function and disability outcomes.

Increasing Research And Development Activities With Respect To CPAP Devices

The increasing focus on research and development (R&D) activities, particularly with respect to Continuous Positive Airway Pressure (CPAP) devices, is playing a pivotal role in driving the demand for respiratory monitoring devices. CPAP devices are widely used to treat obstructive sleep apnea, a common respiratory disorder. Ongoing R&D efforts have led to the development of more advanced and user-friendly CPAP devices. These devices not only improve patient comfort but also enhance treatment efficacy. To monitor the effectiveness of CPAP therapy, respiratory monitoring devices are often employed to track parameters like oxygen saturation, airflow, and respiratory rate.

R&D activities are driving the transition toward personalized medicine in the field of respiratory care. By integrating respiratory monitoring devices with CPAP therapy, healthcare providers can tailor treatment plans to individual patient needs, optimizing therapeutic outcomes. CPAP devices are increasingly equipped with data collection and transmission capabilities. The integration of respiratory monitoring devices allows for the collection of comprehensive data on sleep patterns, breathing irregularities, and treatment compliance. This data-driven approach supports better patient management and therapeutic adjustments.

Key Market Challenges

High Cost of Devices

High device cost remains a meaningful restraint in India’s respiratory monitoring market because the price gap between basic home-use tools and advanced monitoring systems can strongly influence purchasing decisions by both patients and healthcare providers. While lower-cost devices such as pulse oximeters are becoming relatively accessible for household use, advanced solutions like capnography and integrated monitoring systems still involve substantially higher upfront spending, making them harder to adopt widely in price-sensitive settings. This affordability challenge is even more pronounced in smaller hospitals and resource-constrained care environments, where procurement budgets, maintenance requirements, and limited reimbursement can push providers toward traditional spirometers, peak flow meters, or basic oxygen monitoring rather than more sophisticated respiratory surveillance platforms.

The result is a segmented market in which adoption rises for essential low-cost monitoring, but advanced respiratory monitoring remains uneven despite its clinical value in early detection, ventilation management, and continuous patient assessment. For Instance, Apollo HomeCare lists a pulse oximeter at about 979 rupees and a 5 litre per minute oxygen concentrator at 45,939 rupees, while IndiaMART listings show capnograph systems at around 45,000 rupees and capnograph units with pulse oximetry at about 120,000 rupees, clearly illustrating how device prices can limit broader uptake of higher-end respiratory monitoring technologies.

Limited Reimbursement Coverage

Limited reimbursement and insurance coverage remain important barriers in India’s respiratory monitoring market because patient adoption is highly sensitive to out-of-pocket spending, especially when devices are needed for long-term home management of sleep apnea, chronic respiratory disease, or oxygen support after hospitalization. When coverage is partial or conditional, patients may delay purchases, choose only the most essential device, or avoid advanced monitoring altogether, which can restrict timely diagnosis, weaken adherence, and influence clinicians to recommend lower-cost options that are more financially realistic for households.

This challenge is even more relevant in India because respiratory care often involves not just the machine itself but recurring expenditure on masks, tubing, filters, and related supplies, so affordability affects continued use as much as initial acquisition. Healthcare providers and payers are therefore becoming critical gatekeepers in device uptake, since broader reimbursement can materially improve access and make home-based respiratory monitoring more practical for a larger patient pool. For Instance, New India Assurance offers a durable medical devices rider covering up to 10 percent of the sum insured with a maximum of 1 lakh rupees and includes oxygen concentrators, ventilators, CPAP, and spirometers, while government reimbursement ceilings under CGHS and CS MA guidelines are set at 45,000 rupees for oxygen concentrators and CPAP and 68,000 rupees for BiPAP.

Key Market Trends

Alarming Rise In Pollution Levels

The sharp rise in pollution levels is increasing demand for respiratory monitoring devices in India. Air pollution, particularly in urban areas, is linked to conditions such as asthma and chronic obstructive pulmonary disease (COPD). The State of Global Air 2024 reports that air pollution causes over 2 million deaths annually in India, while globally it accounted for 8.1 million deaths in 2024. In Delhi, more than 2 lakh cases of acute respiratory illness were reported between 2022 and 2024, with over 30,000 hospitalizations and 68,411 cases recorded in 2024.

Studies indicate a 31% increase in hospital admissions between 2019 and 2024, along with a strong correlation between PM2.5 levels and respiratory diseases. Air pollution accounts for a significant share of COPD-related health burden in India. This has led to increased use of respiratory monitoring devices such as peak flow meters and spirometers. Additionally, portable and smartphone-enabled devices, including innovations like Cipla’s Spirofy, are supporting wider adoption.

Growing Healthcare Awareness And Expenditure

Growing healthcare awareness and expenditure are key factors driving the increased demand for respiratory monitoring devices. As individuals become more health-conscious, they are more likely to invest in preventative and diagnostic equipment, including respiratory monitors. These devices offer invaluable insights into respiratory health, enabling earlier detection and treatment of potential issues. Coupled with rising disposable income, consumers are better positioned to afford such devices, contributing to market growth.

Additionally, governments and healthcare institutions globally are dedicating more resources to healthcare, including expenditure on advanced medical devices. This investment not only ensures the availability of cutting-edge equipment but also facilitates extensive research and development efforts, which further expand the capabilities and effectiveness of respiratory monitoring devices. The COVID-19 pandemic has notably heightened awareness of respiratory health, creating an immediate and urgent demand for these devices. In the long term, this greater emphasis on respiratory health is likely to sustain, if not increase, this demand. Thus, it is evident that growing healthcare awareness and expenditure are collectively fueling the rising need for respiratory monitoring devices.

Segmental Insights

Type Insights

Based on Type, Therapeutic Devices is anticipated to dominate the India Respiratory Monitoring Market during the forecast period. This is primarily attributed to their broad usage in managing various respiratory disorders, including asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea. Therapeutic devices, such as nebulizers, inhalers, and continuous positive airway pressure (CPAP) machines, are designed to provide targeted treatment and support to individuals with respiratory conditions. They offer precise medication delivery, ensuring effective symptom management and improved respiratory function. Moreover, these devices are known for their durability and long-lasting nature, making them reliable companions for long-term therapy.

The increasing prevalence of respiratory diseases in the country further fuels the demand for these devices, as they play a crucial role in improving the quality of life for individuals affected by such conditions. The rise in pollution levels, unhealthy lifestyle choices, and occupational hazards contribute to the growing burden of respiratory disorders. As a result, the need for therapeutic devices has become even more significant, as they help in alleviating symptoms, reducing hospitalizations, and enhancing overall well-being. In addition to their therapeutic benefits, these devices also offer convenience and ease of use. With advancements in technology, many therapeutic devices are now portable, compact, and user-friendly. This allows patients to carry out their treatment regimen at home or on the go, ensuring uninterrupted care and improved adherence to prescribed therapies.

End User Insights

Based on End User, Hospitals is anticipated to dominate the India Respiratory Monitoring Market during the forecast period. These hospitals boast state-of-the-art equipment and a team of highly skilled healthcare professionals with expertise in respiratory care. Their extensive range of services covers the diagnosis, treatment, and management of various respiratory conditions, ensuring optimal care for patients.

The rising prevalence of respiratory diseases in India has further emphasized the importance of hospitals in the Indian Respiratory Monitoring Market. With the growing awareness about health and the need for regular monitoring, hospitals have become the go-to choose for individuals seeking respiratory care. This has contributed to their significant market share and continued dominance in the industry.

What sets hospitals apart is their unwavering commitment to delivering high-quality healthcare services. They continuously invest in advanced technologies and stay updated with the latest research and advancements in respiratory monitoring. This allows them to adapt to the evolving needs of patients and deliver personalized care that is tailored to each individual's unique requirements.

Download Free Sample Report

Regional Insights

Based on Region, North India is anticipated to dominate the India Respiratory Monitoring Market during the forecast period. North India, especially Delhi and its surrounding areas, frequently faces severe air pollution problems. The region often records high levels of particulate matter (PM2.5 and PM10), nitrogen dioxide (NO2), sulfur dioxide (SO2), and other air pollutants. Prolonged exposure to such pollutants increases the risk of respiratory conditions, such as asthma, bronchitis, and COPD, leading to a greater need for respiratory monitoring and care.

During the winter months, North India experiences cold and foggy weather, which can exacerbate respiratory issues. Cold air can trigger asthma attacks and worsen respiratory symptoms in individuals with pre-existing conditions. Consequently, residents in these areas may require respiratory monitoring devices to manage their health during the colder seasons.

North India is densely populated, with large metropolitan areas like Delhi, Noida, and Gurgaon. The concentration of people in urban areas can lead to increased exposure to pollutants and a higher prevalence of respiratory conditions, driving the demand for monitoring devices. North India boasts a significant healthcare infrastructure, with numerous hospitals, clinics, and healthcare facilities. The availability of healthcare services and specialized medical practitioners increases awareness and access to respiratory monitoring devices.

Recent Developments 

• In January 2025, ResMed launched AirSense 11 in India, introducing a next-generation CPAP platform for sleep apnea that also strengthens respiratory monitoring through connected digital tools. In January 2025, the device was launched with the myAir patient engagement app and the AirView clinician platform, allowing users and providers to track nightly breathing data, adherence, mask removal, and apnea events remotely, which made the rollout a notable product launch in home-based respiratory monitoring.

• In July 2025, Bengaluru-based Dozee received CE Mark certification under the EU Medical Device Regulation for its remote patient monitoring system, which continuously measures respiration rate along with heart rate, temperature, SpO₂, blood pressure, and movement. In July 2025, this was a meaningful innovation milestone for India’s respiratory monitoring field because the clinically validated, contactless platform gained international regulatory recognition, reinforcing the scalability of Indian-developed continuous respiratory surveillance technology for hospitals.

• In November 2025, Yashoda Hospital, Hitech City launched an AI-enabled Lung Nodule Clinic in collaboration with Qure.ai and AstraZeneca to improve earlier detection and structured follow-up of lung disease. In November 2025, the programme embedded AI into chest X-ray workflows to flag, risk-stratify, and track lung nodules, and early reporting from the rollout said more than 17,000 X-rays had been analysed, making it a notable collaboration-led advance in imaging-based respiratory monitoring and clinical decision support.

• In July 2025, an ICMR-National Institute of Epidemiology study called for India to move from seasonal to year-round monitoring of influenza-like illness and severe acute respiratory infections. In July 2025, while this was not a product launch, it was a major monitoring-related development because the researchers specifically recommended continuous surveillance, stronger laboratory capacity, and better reporting systems, signaling a broader shift toward more structured and technology-supported respiratory monitoring across the country.

Key Market Players

• Philips India Ltd
• Resmed India Pvt Ltd
• GlaxoSmithKline Pharmaceuticals Limited
• India Medtronic Pvt. Ltd.
• Fisher & Paykel Healthcare Ltd
• Getinge Medical India Pvt. Ltd.
• Masimo Medical Technologies India Pvt Ltd

Report Scope:

In this report, the India Respiratory Monitoring Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• India Respiratory Monitoring Market, By Diagnostic and Monitoring Devices:

o Spirometers

o Sleep Test Devices

o Peak Flow Meters

o Pulse Oximeters

o Capnographs

o Others

• India Respiratory Monitoring Market, By Type:

o Therapeutic Devices

o Disposables

• India Respiratory Monitoring Market, By End User:

o Home care

o Hospitals

o Ambulatory Surgical Centres

o Specialty Clinics

• India Respiratory Monitoring Market, By Region:

o North India

o South India

o West India

o East India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the India Respiratory Monitoring Market.

Available Customizations:

India Respiratory Monitoring Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).